Logos Global Management LP Avidity Biosciences, Inc. Transaction History

Logos Global Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$4.87 - $9.37 $3.77 Million - $7.26 Million	775,000 New	775,000 $7.01 Million
Q1 2021 May 17, 2021	SELL	$20.28 - $28.15 $13.6 Million - $18.9 Million	-671,454 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$24.73 - $35.12 $1.24 Million - $1.76 Million	-50,000 Reduced 6.93%	671,454 $17.1 Million
Q3 2020 Nov 16, 2020	SELL	$23.35 - $35.94 $4.79 Million - $7.37 Million	-205,000 Reduced 22.13%	721,454 $20.3 Million
Q2 2020 Aug 14, 2020	BUY	$26.62 - $31.5 $24.7 Million - $29.2 Million	926,454 New	926,454 $25.6 Million

249

107M

224K

161K

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $1.81B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.